Type | Corporation |
---|---|
Industry | Biotechnology |
Founded | 2003 |
Headquarters | Boulder, Colorado |
Key people | Dr. Kathy Rowlen, CEO and CSO |
Products | Virus Quantification, Instrumentation, Pathogen Detection & Identification |
Website | http://www.indevr.com/ |
InDevR is a biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, with product focus on Virus Quantification and pathogen detection / identification. InDevR Inc. is a privately held, woman-owned small business located in Boulder, Colorado, USA.
Contents |
The company was founded in 2003 by Kathy L. Rowlen, Laura R. Kuck, and John W. Birks as an LLC. The origin of the name derived from its early stage goals of Instrument Development and Research. The company converted to a corporation in 2005 with a shift toward product sales and customer support.
In 2005, InDevR purchased majority ownership of 2B Technologies, a leader in the field of analytical instruments for atmospheric and environmental measurements. An ISO 9001:2000-certified manufacturer, 2B Technologies has produced and sold over 2,000 ozone monitors and related instruments.
InDevR is an excellent example of the effectiveness of the Small Business Innovation Research program sponsored by the federal government. The company received a Phase I grant in 2006 to develop a revolutionary instrument for Virus Quantification from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Based on demonstration of feasibility in Phase I, InDevR received a Phase II grant in 2008. Both of these grants led directly to the creation of several high-tech jobs that continue to date as InDevR translated the funding for research and development into the commercially available Virus Counter product line.
In addition to the Virus Counter product line, the company continues to develop new, innovative and cost-effective tools, such as the FluChip, to improve analysis of viruses and other micro-organisms. The FluChip was invented by a joint team of scientists at the University of Colorado at Boulder and the Centers for Disease Control and Prevention (Atlanta) in an NIAID-supported effort led by then-Professor Kathy Rowlen. InDevR licensed the intellectual property from the University of Colorado and CDC in 2009. Identification of influenza viruses using the FluChip is one application InDevR is targeting in their development of a fully automated molecular diagnostics platform. [1] [2]